Welcome!

News Feed Item

Los Angeles Research Sites Investigating Medical Device Proven to Restore Vision and Improve Quality of Life in Seniors

Drs. David Boyer and Samuel Masket Now Enrolling Patients for the CentraSight Study

LOS ANGELES, CA -- (Marketwired) -- 08/18/14 -- Dr. David Boyer with Retina-Vitreous Associates Medical Group and Dr. Samuel Masket with Advanced Vision Care today announced they are participating in a nationwide, post-approval study of the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), a medical device already approved by the FDA to restore vision and improve quality of life in people living with end-stage age-related macular degeneration (AMD) and meeting specific vision and cornea health criteria.

The study is designed to corroborate the safety data submitted to the U.S. Food and Drug Administration that led to approval and evaluate the patient care program in a commercial setting. Both Retina-Vitreous Associates Medical Group and Advanced Vision are actively seeking patients to participate in the telescope implant treatment program.

Smaller than a pea, the telescope implant uses micro-optical technology to magnify images which would normally be seen in one's straight ahead vision. The images are projected onto the healthy portion of the retina not affected by the disease, making it possible for patients to see or discern the central vision object of interest.

The CentraSight® program has been developed to help patients see the things that are important to them, regain independence, and re-engage in everyday activities. The program utilizes a multispecialty provider team approach to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care. The specially trained team includes a retina specialist, cornea surgeon, low vision optometrist and low vision occupational therapist, the latter whom works with the patient over several months to teach them how to use his/her new vision. The telescope implant is the only approved surgical device for end-stage AMD and the treatment is Medicare eligible.

"We have been offering the telescope implant surgery to patients in the LA metro area since 2011," said Dr. Samuel Masket. "We've been impressed with patients' progress following the out-patient procedure as they become proficient in using this remarkable, implanted device. Patients report they are resuming hobbies, living more independently and, most importantly, seeing the faces of their family and friends."

About End-Stage AMD

More than 15 million Americans are affected by some form of macular degeneration and approximately 2 million Americans have advanced forms of AMD with associated vision loss. The number of Americans afflicted with macular degeneration is expected to double with the rapid aging of the U.S. population. Specifically, end-stage AMD results in a loss of central or "straight-ahead" vision, creating a blind spot, and is uncorrectable by glasses, drugs or cataract surgery. This blind spot makes it difficult or impossible for patients to see faces, read, and perform everyday activities such as watching TV, preparing meals, and self-care. The telescope implant has been demonstrated in earlier clinical trials to improve quality of life for those with central vision loss in both eyes by improving patients' vision so they can see the things that are important to them, increase their independence, and re-engage in everyday activities. It also may help patients in social settings as it may allow them to recognize faces and see the facial expressions of family and friends.

Retina-Vitreous Associates Medical Group and Advanced Vision Care are actively seeking patients whom might be candidates for the telescope implant. Upon contacting either of these practices, patients will be evaluated for the study participation by determining if they:

  • Have irreversible, End-Stage AMD resulting from either dry or wet AMD in both eyes
  • Are no longer a candidate for drug treatment
  • Have not had cataract surgery in the eye where the telescope will be implanted and have adequate peripheral vision in the eye not scheduled for surgery
  • Are age 75 or older and meet other vision/cornea health requirements

The CentraSight treatment program in Los Angeles includes Dr. David Boyer, who coordinates the treatment; Dr. Samuel Masket, who performs the surgery at Good Samaritan Hospital; and the Center for Partially Sighted, who coordinates the post-surgical rehabilitation for the patient.

The telescope implant is not a cure for End-stage AMD. As with any medical intervention, potential risks and complications exist with the telescope implant. Possible side effects include decreased vision or vision impairing corneal swelling. The risks and benefits associated with the telescope implant are discussed in the Patient Information Booklet available at www.CentraSight.com and will be evaluated with each patient who might be a candidate for this study.

Patients and physicians can find more information about the telescope implant and related treatment program by calling Advanced Vision Care at 310-229-1220 or by visiting www.CentraSight.com or calling 1-877-99-SIGHT.

About Advanced Vision Care

Advanced Vision Care is dedicated to providing state-of-the-art, individually based, high quality, eye health care. Drs. Samuel Masket, Nicole Fram and Juliet Chung are board-certified skilled ophthalmologists that provide a variety of services to help you attain the clearest vision possible. Our services cover a range of eye problems including cataracts, glaucoma, corneal disease and dry eye, retinal disorders, and ocular injuries. We have the common goal of ascertaining the most appropriate care for any given patient, explaining the purpose of the treatment, and in initiating said therapy in a courteous and compassionate manner irrespective of age, gender, nationality, race, or payment program. For more information, go to www.advancedvisioncare.com.

About Retina-Vitreous Associates Medical Group

Retina-Vitreous Associates Medical Group specializes in the treatment of diseases affecting the back of the eye, specifically those of the retina, vitreous, and macula. Patients are typically referred by their general ophthalmologist when a retinal problem is suspected. They care for patients with macular degeneration, diabetic retinopathy, retinal detachment, retinal vein occlusions, uveitis, ocular tumors and pediatric retinal diseases.

They have seven office locations. Each is equipped with state of the art diagnostic equipment and treatment facilities. RVAMG is also extremely active in clinical research, community education and participates in a number of various clinical studies evaluating new treatments. They are dedicated to providing the best possible care, and can provide patient access to the most current treatment options. For more information, go www.laretina.com.

About CentraSight

CentraSight is a first-of-kind treatment program that utilizes a tiny telescope implant for End-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans. Patients with End-stage AMD have a central blind spot or missing area in their vision that makes it difficult or impossible to see faces, read, and perform everyday activities. The CentraSight treatment program allows patients to see details again by implanting a tiny telescope in the eye in an outpatient procedure, then coordinating with low vision specialists to help the patient learn how to use their new vision for everyday activities. For more information, visit www.CentraSight.com.

Media Contact:

Jennifer Heinly
J&J Consulting
949-716-9829
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that Ocean9will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Ocean9 provides cloud services for Backup, Disaster Recovery (DRaaS) and instant Innovation, and redefines enterprise infrastructure with its cloud native subscription offerings for mission critical SAP workloads.
In his session at @ThingsExpo, Eric Lachapelle, CEO of the Professional Evaluation and Certification Board (PECB), will provide an overview of various initiatives to certifiy the security of connected devices and future trends in ensuring public trust of IoT. Eric Lachapelle is the Chief Executive Officer of the Professional Evaluation and Certification Board (PECB), an international certification body. His role is to help companies and individuals to achieve professional, accredited and worldw...
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle.
Providing the needed data for application development and testing is a huge headache for most organizations. The problems are often the same across companies - speed, quality, cost, and control. Provisioning data can take days or weeks, every time a refresh is required. Using dummy data leads to quality problems. Creating physical copies of large data sets and sending them to distributed teams of developers eats up expensive storage and bandwidth resources. And, all of these copies proliferating...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
SYS-CON Events announced today that Technologic Systems Inc., an embedded systems solutions company, will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Technologic Systems is an embedded systems company with headquarters in Fountain Hills, Arizona. They have been in business for 32 years, helping more than 8,000 OEM customers and building over a hundred COTS products that have never been discontinued. Technologic Systems’ pr...
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
The taxi industry never saw Uber coming. Startups are a threat to incumbents like never before, and a major enabler for startups is that they are instantly “cloud ready.” If innovation moves at the pace of IT, then your company is in trouble. Why? Because your data center will not keep up with frenetic pace AWS, Microsoft and Google are rolling out new capabilities In his session at 20th Cloud Expo, Don Browning, VP of Cloud Architecture at Turner, will posit that disruption is inevitable for c...
SYS-CON Events announced today that Cloudistics, an on-premises cloud computing company, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloudistics delivers a complete public cloud experience with composable on-premises infrastructures to medium and large enterprises. Its software-defined technology natively converges network, storage, compute, virtualization, and management into a ...
Deep learning has been very successful in social sciences and specially areas where there is a lot of data. Trading is another field that can be viewed as social science with a lot of data. With the advent of Deep Learning and Big Data technologies for efficient computation, we are finally able to use the same methods in investment management as we would in face recognition or in making chat-bots. In his session at 20th Cloud Expo, Gaurav Chakravorty, co-founder and Head of Strategy Development ...
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor - all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
SYS-CON Events announced today that Loom Systems will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2015, Loom Systems delivers an advanced AI solution to predict and prevent problems in the digital business. Loom stands alone in the industry as an AI analysis platform requiring no prior math knowledge from operators, leveraging the existing staff to succeed in the digital era. With offices in S...
What if you could build a web application that could support true web-scale traffic without having to ever provision or manage a single server? Sounds magical, and it is! In his session at 20th Cloud Expo, Chris Munns, Senior Developer Advocate for Serverless Applications at Amazon Web Services, will show how to build a serverless website that scales automatically using services like AWS Lambda, Amazon API Gateway, and Amazon S3. We will review several frameworks that can help you build serverle...
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...